The Nutra Healthspan Summit returns for its second edition with two days at Convene 133 Houndsditch in the City of London, organised by NutraIngredients, part of William Reed Business Media and one of the established publishers covering nutrition science and the supplements sector.
The summit sits where nutrition science meets commercial strategy. Programming covers the evidence behind healthspan-focused nutrition — protein and sarcopenia, NAD+ precursors, polyphenols, omega-3s, the gut microbiome, time-restricted eating and metabolic interventions — alongside the regulatory and commercial questions that determine what can be sold and what can be claimed. European and UK health-claim regulation, clinical substantiation standards, personalised nutrition, and the role of biomarkers in demonstrating benefit all feature.
The audience is predominantly industry: nutrition scientists, R&D leads, regulatory affairs professionals, brand and category managers, and the clinicians and dietitians who advise them. That commercial orientation is the point. A large share of what patients actually take for healthy ageing comes from the supplement aisle rather than a prescription pad, and this is one of the few meetings where the evidence behind those products is examined openly alongside how they are marketed.
For dietitians, clinical nutritionists, pharmacists and preventive-medicine physicians in Saudi Arabia and the Gulf, the summit is useful for exactly that reason: patients arrive already taking these compounds, and knowing where the evidence is strong, thin or absent is a practical clinical need. The regulatory sessions are also relevant given the region's tightening rules on supplement claims.
The event has been covered by NutraIngredients through 2026 and is confirmed as an annual fixture. Registration, ticket pricing, the agenda and the speaker list are published by the organiser; delegates should confirm details directly before booking travel to London.
